The impact of interindividual variation in NAT2 activity on benzidine urinary metabolites and urothelial DNA adducts in exposed workers

Proceedings of the National Academy of Sciences of the United States of America

Volumn 93, Issue 10, 1996, Pages 5084-5089

  Rothman, N ^a   Bhatnagar, V K ^b   Hayes, R B ^a   Zenser, T V ^c   Kashyap, S K ^b   Butler, M A ^d   Bell, D A ^e   Lakshmi, V ^c   Jaeger, M ^f   Kashyap, R ^b   Hirvonen, A ^e   Schulte, P A ^d   Dosemeci, M ^a   Hsu, F ^c   Parikh, D J ^b   Davis, B B ^c   Talaska, G ^f  

^a NATIONAL CANCER INSTITUTE   (United States)

^b NATIONAL INSTITUTE OF OCCUPATIONAL HEALTH   (India)

^c SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH   (United States)

^e NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^f UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BENZIDINE;

ADULT; ARTICLE; BLADDER CANCER; BLADDER CARCINOGENESIS; CANCER RISK; CHEMICAL CARCINOGENESIS; CLINICAL ARTICLE; CONTROLLED STUDY; GENETIC VARIABILITY; HUMAN; OCCUPATIONAL EXPOSURE; PRIORITY JOURNAL; UROTHELIUM;

ADULT; ARYLAMINE N-ACETYLTRANSFERASE; BENZIDINES; CARCINOGENS; CROSS-SECTIONAL STUDIES; DNA ADDUCTS; HUMANS; INDIA; MALE; OCCUPATIONAL EXPOSURE; PHENOTYPE; RISK FACTORS; URINARY BLADDER; URINARY BLADDER NEOPLASMS; VARIATION (GENETICS);

EID: 9344264042     PISSN: 00278424     EISSN: None     Source Type: Journal    
DOI: 10.1073/pnas.93.10.5084     Document Type: Article

References (50)

1. Morton, K. C., Wang, C. Y., Garner, C. D. & Shirai, T. (1981) Carcinogenesis 2, 747-752.
2. Weber, W. W. (1987) The Acetylator Genes and Drug Response (Oxford Univ. Press, NY).
3. Kennelly, J. C., Beland, F. A., Kadlubar, F. F. & Martin, C. N. (1984) Carcinogenesis 5, 407-412.
4. Frederick, C. B., Weis, C. C., Flammang, T. J., Martin, C. N. & Kadlubar, F. F. (1985) Carcinogenesis 6, 959-965.
5. Zenser, T. V., Mattammal, M. B., Wise, R. W., Rice, J. R. & Davis, B. B. (1983) J. Pharmacol. Exp. Ther. 227, 545-550.
6. Flammang, T. J., Yamazoe, Y., Benson, R. W., Roberts, D. W., Potter, D. W., Chu, D. Z. J., Lang, N. P. & Kadlubar, F. F. (1989) Cancer Res. 49, 1977-1982.
7. Blum, M., Demierre, A., Grant, D. M., Heim, M. & Meyer, U. A. (1991) Proc. Natl. Acad. Sci. USA 88, 5237-5241.
8. Vatsis, K. P., Martell, K. J. & Weber, W. W. (1991) Proc. Natl. Acad. Sci. USA 88, 6333-6337.
9. Lower, G. M., Nilsson, T., Nelson, C. E., Wolf, H., Gamsky, T. E. & Bryan, G. T. (1979) Environ. Health Perspect. 29, 71-79.
10. Hein, D. W. (1988) Biochim. Biophys. Acta 948, 37-66.
11. Risch, A., Wallace, D. M. A., Bathers, S. & Sim, E. (1995) Hum. Mol. Genet. 4, 231-236.
12. Cartwright, R. A., Rogers, H. J., Barham-Hall, D., Glashan, R. W., Ahmad, R. A., Higgins, E. & Kahn, M. A. (1982) Lancet ii, 842-846.
13. Hanke, J. & Krajewska, B. (1990) J. Occup. Med. 32, 917-918.
14. International Agency for Research on Cancer (1972) IARC Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans (IARC, Lyon, France), No. 1, pp. 80-86.
15. International Agency for Research on Cancer (1974) IARC Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans: Some Aromatic Amines, Hydrazine, and Related Substances, N-Nitroso Compounds and Miscellaneous Alkylating Agents (IARC, Lyon, France), No. 4, pp. 97-111.
16. Bi, W., Hayes, R. B., Feng, P., Qi, Y., You, X., Zhen, J., Zhang, M., Qu, B., Fu, Z., Chen, M., Chien, H. T. C. & Blot, W. J. (1992) Am. J. Ind. Med. 21, 481-489.
17. Hayes, R. B., Bi, W., Rothman, N., Broly, F., Caporaso, N., Feng, P., You, X., Yin, S., Woosley, R. L. & Meyer, U. A. (1993) Carcinogenesis 14, 675-678.
18. Rothman, N., Hayes, R. B., Bi, W., Caporaso, N., Broly, F., Woosley, R. L., Yin, S., Feng, P., You, X. & Meyer, U. A. (1993) Pharmacogenetics 3, 250-255.
19. Morinaga, K., Yutani, S. & Hara, I. (1990) Nippon Eiseigaku Zasshi 45, 909-918.
20. You, X.-Y., Chen, J.-G. & Hu, Y.-N. (1990) Br. J. Ind. Med. 47, 544-552.
21. Mancuso, T. F. & El-Attar, A. A. (1967) J. Occup. Med. 9, 277-285.
22. Meigs, J. W., Marrett, L. D., Ulrich, F. U. & Flannery, J. T. (1986) J. Natl. Cancer Inst. 76, 1-8.
23. Martin, C. N., Beland, F. A., Roth, R. W. & Kadlubar, F. F. (1982) Cancer Res. 42, 2678-2686.
24. Talaska, G., Au, W. W., Ward, J. B., Jr., Randerath, K. & Legator, M. S. (1987) Carcinogenesis 8, 1899-1905.
25. Lakshmi, V. M., Zenser, T. V., Goldman, H. D., Spencer, G. G., Gupta, R. C., Hsu, F. F. & Davis, B. B. (1995) Chem. Res. Toxicol. 8, 711-720.
26. Radomski, J. L. (1979) Annu. Rev. Pharmacol. Toxicol. 19, 129-157.
27. Butler, M. A., Lang, N. P., Young, J. F., Caporaso, N. E., Vineis, P., Hayes, R. B., Teitel, C. H., Massengill, J. P., Lawsen, M. F. & Kadlubar, F. F. (1992) Pharmacogenetics 2, 116-127.
28. Hsu, F.-F., Lakshmi, V., Rothman, N., Bhatnagar, V. K., Hayes, R. B., Kashyap, R., Parikh, D. J., Kashyap, S. K., Turk, J., Zenser, T. & Davis, B. (1996) Anal. Biochem. 234, 183-189.
29. Talaska, G., Schamer, M., Skipper, P., Tannenbaum, S., Caporaso, N., Unruh, L., Kadlubar, F. F., Bartsch, H., Malaveille, C. & Vineis, P. (1991) Cancer Epidemiol. Biomarkers Prev. 1, 61-66.
30. Gupta, R. C. (1984) Proc. Natl. Acad. Sci. USA 81, 6943-6947.
31. Talaska, G., Dooley, K. L. & Kadlubar, F. F. (1990) Carcinogenesis 11, 639-646.
32. Wise, R. W., Zenser, T. V. & Davis, B. B. (1984) Carcinogenesis 5, 1499-1503.
33. Talaska, G., Al-Juburi, A. Z. S. S. & Kadlubar, F. F. (1991) Proc. Natl. Acad. Sci. USA 88, 5350-5354.
34. Bell, D. A., Taylor, J. A., Butler, M. A., Stephens, E A., Wiest, J., Brubaker, L. H., Kadlubar, F. F. & Lucier, G. W. (1993) Carcinogenesis 14, 1689-1692.
35. Lin, H. J., Han, C-Y., Lin, B. K. & Hardy, S. (1993) Am. J. Hum. Genet. 52, 827-834.
36. Bell, D. A., Stephens, E. A., Castranio, T., Umbach, D. M., Watson, M. A., Deakin, M., Elder, J., Hendrickse, C., Duncan, H. & Strange, R. C. (1995) Cancer Res. 55, 3537-3542.
37. Vatsis, K. P., Weber, W. W., Bell, D. A., Dupret, J.-M., Evans, D. A. P., Grant, D. M., Hein, D. W., Lin, H. J., Meyer, U. A., Relling, M. V., Sim, E., Suzuki, T. & Yamazoe, Y. (1995) Pharmacogenetics 5, 1-17.
38. Bell, D. A., Badawi, A. F., Lang, N. P., Ilett, K. F., Kadlubar, F. F. & Hirvonen, A. (1995) Cancer Res. 55, 5226-5229.
39. International Agency for Research on Cancer (1982) IARC Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans: Direct Black 38 (IARC, Lyon, France), No. 29, pp. 295-310.
40. Grant, D. M., Josephy, P. D., Lord, H. L. & Morrison, L. D. (1992) Cancer Res. 52, 3961-3964.
41. Grant, D. M., Blum, M., Beer, M. & Meyer, U. A. (1991) Mol. Pharmacol. 39, 184-191.
42. Kirlin, W. G., Trinidad, A., Yerokun, T., Ogola, F., Ferguson, R. J., Andrews, A. F., Brady, P. K. & Hein, D. W. (1989) Cancer Res. 49, 2448-2454.
43. Kloth, M. T., Gee, R. L., Messing, E. M. & Swaminathan, S. (1994) Carcinogenesis 15, 2781-2787.
44. Badawi, A. F., Hirvonen, A., Bell, D. A., Lang, N. P. & Kadlubar, F. F. (1995) Cancer Res. 55, 5230-5237.
45. Dewan, A., Jani, J. P., Patel, J. S., Gandhi, D. N., Variya, M. R. & Ghodasara, N. B. (1988) Arch. Environ. Health 43, 269-272.
46. Peters, J. H., Gordon, G. R., Lin, E., Green, C. E. & Tyson, C. A. (1990) Anticancer Res. 10, 225-230.
47. Lakshmi, V. M., Bell, D. A., Watson, M. A., Zenser, T. V. & Davis, B. B. (1995) Carcinogenesis 16, 1565-1571.
48. Zavon, M. R., Hoegg, U. & Bingham, E. (1913) Arch. Environ. Health 21, 1-7.
49. Gupta, R. C., Earley, K. & Sharma, S. (1988) Proc. Natl. Acad. Sci. USA 85, 3513-3517.
50. Josephy, P. D. (1986) Fed. Proc. Fed. Am. Soc. Exp. Biol. 45, 2465-2470.